Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | XON7 |
Synonyms | |
Therapy Description |
XON7 is a glyco-humanized polyclonal antibody that targets tumor cells and induces complement dependent cytotoxicity and apoptosis, potentially resulting in tumor growth inhibition (J Clin Oncol 41, 16_suppl (June 01, 2023)). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
XON7 | XON7 is a glyco-humanized polyclonal antibody that targets tumor cells and induces complement dependent cytotoxicity and apoptosis, potentially resulting in tumor growth inhibition (J Clin Oncol 41, 16_suppl (June 01, 2023)). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06154291 | Phase Ib/II | XON7 | FIH XON7 in Advanced/Metastatic Solid Tumors (FIPO23) | Recruiting | FRA | BEL | 0 |